Novelorigin Pharmaceuticals Private Limited
About Novelorigin Pharmaceuticals Private Limited
Data last updated:
Novelorigin Pharmaceuticals Private Limited is a private limited company based in Miraj, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 17 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN2021PTC201858.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Ghatage Piter Shamuwel and Jeni Peter Ghatage.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 10&11 Plot No – 24 F.No.3 Aasha Residancy Madha Colony Near Rama Udyan, Miraj, Maharashtra, India – 416410.
Company details
Contact details
Novelorigin Pharmaceuticals Private Limited's registered office is in Miraj, Maharashtra.
- Registered Address10&11 Plot No – 24 F.No.3 Aasha Residancy Madha Colony Near Rama Udyan, Miraj, Maharashtra, India – 416410
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Novelorigin Pharmaceuticals Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Novelorigin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Novelorigin Pharmaceuticals Private Limited
Novelorigin Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ghatage Piter Shamuwel | Director | 17 Jun 2021 | 5 Years 4 Months | Current |
| Jeni Peter Ghatage Also directs: Aasha Infratech Private Limited, Hadassah Foundation | Director | 17 Jun 2021 | 5 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Novelorigin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novelorigin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Novelorigin Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Novelorigin Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Ghatage Piter Shamuwel was appointed as Director on 17 Jun 2021.
Frequently asked questions
Novelorigin Pharmaceuticals is an active private limited company based in Miraj, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 17 June 2021 (5+ years old) and is registered under CIN U24239PN2021PTC201858.
Novelorigin Pharmaceuticals has 2 current directors:
- Ghatage Piter Shamuwel - Director
- Jeni Peter Ghatage - Director
The latest financial statements of Novelorigin Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Novelorigin Pharmaceuticals is U24239PN2021PTC201858. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novelorigin Pharmaceuticals was incorporated on 17 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
Ghatage Piter Shamuwel was appointed as Director on 17 Jun 2021. Jeni Peter Ghatage was appointed as Director on 17 Jun 2021.
The registered office of Novelorigin Pharmaceuticals is at 10&11 Plot No – 24 F.No.3 Aasha Residancy Madha Colony Near Rama Udyan, Miraj, Maharashtra, India – 416410.
Novelorigin Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Novelorigin Pharmaceuticals can be reached at its registered office: 10&11 Plot No – 24 F.No.3 Aasha Residancy Madha Colony Near Rama Udyan, Miraj, Maharashtra, India – 416410.
Novelorigin Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Pune.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
